Monocyte activation in systemic Covid-19 infection: Assay and rationale
Mononuclear phagocytes are a widely distributed family of cells contributing to innate and adaptive immunity. Circulating monocytes and tissue macrophages participate in all stages of SARS COVID-19. They contribute to comorbidities predisposing to clinical infection, virus resistance and disseminati...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456455/ https://www.ncbi.nlm.nih.gov/pubmed/32861199 http://dx.doi.org/10.1016/j.ebiom.2020.102964 |
_version_ | 1783575802646888448 |
---|---|
author | Martinez, Fernando O. Combes, Theo W. Orsenigo, Federica Gordon, Siamon |
author_facet | Martinez, Fernando O. Combes, Theo W. Orsenigo, Federica Gordon, Siamon |
author_sort | Martinez, Fernando O. |
collection | PubMed |
description | Mononuclear phagocytes are a widely distributed family of cells contributing to innate and adaptive immunity. Circulating monocytes and tissue macrophages participate in all stages of SARS COVID-19. They contribute to comorbidities predisposing to clinical infection, virus resistance and dissemination, and to host factors that determine disease severity, recovery and sequelae. Assays are available to detect viral infection and antibody responses, but no adequate tests have been developed to measure the activation level of monocytes and tissue macrophages, and the risk of progression to a fatal hyperinflammatory syndrome. Blood monocytes provide a window on the systemic immune response, from production to tissue recruitment, reflecting the impact of infection on the host. Ready availability of blood makes it possible to monitor severity and the risk of potentially lethal complications, by developing tests to assess the status of monocyte activation and its potential for further inflammatory dysregulation after recruitment to tissues and during recovery. |
format | Online Article Text |
id | pubmed-7456455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-74564552020-08-31 Monocyte activation in systemic Covid-19 infection: Assay and rationale Martinez, Fernando O. Combes, Theo W. Orsenigo, Federica Gordon, Siamon EBioMedicine Review Mononuclear phagocytes are a widely distributed family of cells contributing to innate and adaptive immunity. Circulating monocytes and tissue macrophages participate in all stages of SARS COVID-19. They contribute to comorbidities predisposing to clinical infection, virus resistance and dissemination, and to host factors that determine disease severity, recovery and sequelae. Assays are available to detect viral infection and antibody responses, but no adequate tests have been developed to measure the activation level of monocytes and tissue macrophages, and the risk of progression to a fatal hyperinflammatory syndrome. Blood monocytes provide a window on the systemic immune response, from production to tissue recruitment, reflecting the impact of infection on the host. Ready availability of blood makes it possible to monitor severity and the risk of potentially lethal complications, by developing tests to assess the status of monocyte activation and its potential for further inflammatory dysregulation after recruitment to tissues and during recovery. Elsevier 2020-08-30 /pmc/articles/PMC7456455/ /pubmed/32861199 http://dx.doi.org/10.1016/j.ebiom.2020.102964 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Martinez, Fernando O. Combes, Theo W. Orsenigo, Federica Gordon, Siamon Monocyte activation in systemic Covid-19 infection: Assay and rationale |
title | Monocyte activation in systemic Covid-19 infection: Assay and rationale |
title_full | Monocyte activation in systemic Covid-19 infection: Assay and rationale |
title_fullStr | Monocyte activation in systemic Covid-19 infection: Assay and rationale |
title_full_unstemmed | Monocyte activation in systemic Covid-19 infection: Assay and rationale |
title_short | Monocyte activation in systemic Covid-19 infection: Assay and rationale |
title_sort | monocyte activation in systemic covid-19 infection: assay and rationale |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456455/ https://www.ncbi.nlm.nih.gov/pubmed/32861199 http://dx.doi.org/10.1016/j.ebiom.2020.102964 |
work_keys_str_mv | AT martinezfernandoo monocyteactivationinsystemiccovid19infectionassayandrationale AT combestheow monocyteactivationinsystemiccovid19infectionassayandrationale AT orsenigofederica monocyteactivationinsystemiccovid19infectionassayandrationale AT gordonsiamon monocyteactivationinsystemiccovid19infectionassayandrationale |